EpiPen maker Mylan to pay $465M to settle claims it overbilled Medicaid

Doug G. Ware
CANONSBURG, Pa., Oct. 7 (UPI) — Embattled pharma company Mylan agreed Friday to pay nearly a half-million dollars to settle claims it overbilled Medicaid for its life-saving EpiPen product. …read more

Source:: National and World Stories

      

You must be logged in to post a comment Login